AEON
Biotechnology · Healthcare
CEO, Board Member
2025-04-29–present
Board Member
AEON Biopharma, Inc. (AEON)Equibles does not estimate personal net worth.
Robert Bancroft is recorded as CEO and Board Member at AEON Biopharma, Inc. (AEON) since April 29, 2025. AEON Biopharma, Inc. reported in an 8-K filed April 21, 2025 that Robert Bancroft was appointed member of the Board, effective April 29, 2025. AEON Biopharma, Inc. reported in an 8-K filed April 21, 2025 that Robert Bancroft was appointed Principal Executive Officer, President, Chief Executive Officer, effective April 29, 2025. The proxy statement of AEON Biopharma, Inc. reports total compensation of $553,855 for Robert Bancroft in fiscal 2025, including a base salary of $286,438. Disclosed compensation is on record for 2 fiscal years. AEON Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at AEON Biopharma, Inc. includes Jost Fischer (CEO, Chairman and Board Member), Marc Forth (CEO, CFO and Board Member), John Bencich (CFO) and 7 others.
“On April 19, 2025, the board of directors (the “Board”) of AEON BioPharma, Inc. (the “Company”) appointed Robert Bancroft, age 60, as the Company’s Principal Executive Officer, President, Chief Executive Officer and member of the Board to serve as a Class I director, effective as of April 29, 2025.”
“On April 19, 2025, the board of directors (the “Board”) of AEON BioPharma, Inc. (the “Company”) appointed Robert Bancroft, age 60, as the Company’s Principal Executive Officer, President, Chief Executive Officer and member of the Board to serve as a Class I director, effective as of April 29, 2025.”
2025-04-29–present
2025-04-29–present
AEON
Biotechnology · Healthcare
CEO, Board Member
2025-04-29–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | AEON Biopharma, Inc. (AEON) | President and Chief Executive Officer | $286,438 | $553,855 |
| 2024 | AEON Biopharma, Inc. (AEON) | President and Chief Executive Officer | — | — |